Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports

Eupraxia Pharmaceuticals Inc. (EPRX : TSX)

Sector: Healthcare

Close
(01-09-2026)
$11.26
Change
-$0.63 (-5.30%)
Volume 132,507
Open $11.63
Day Range $11.09 - $12.10
52 Week Low $3.96
52 Week High $12.00
Annual Yield -
Annual Dividend -
Last Dividend -
Industry Sector Healthcare
Quoted Market Value $570,300,207
Shares Outstanding 50,648,331
Book Value per Share $10.34
Earnings per Share -$1.15
Period
Loading...
Loading...

Legend

Eupraxia Pharmaceuticals Inc.

Compare Options


Pricing History (Last 30 Days)

Pricing History
Date Close Change
January 09, 2026 11.26
-$0.63 (-5.30%)
January 08, 2026 11.89
$1.67 (16.34%)
January 07, 2026 10.22
-$0.13 (-1.26%)
January 06, 2026 10.35
-$0.34 (-3.18%)
January 05, 2026 10.69
$0.23 (2.20%)
January 02, 2026 10.46
$0.14 (1.36%)
January 01, 2026 10.32
$0.00 (0.00%)
December 31, 2025 10.32
-$0.09 (-0.86%)
December 30, 2025 10.41
-$0.22 (-2.07%)
December 29, 2025 10.63
$0.61 (6.09%)
December 26, 2025 10.02
$0.00 (0.00%)
December 25, 2025 10.02
$0.00 (0.00%)
December 24, 2025 10.02
$0.02 (0.20%)
December 23, 2025 10.00
$0.30 (3.09%)
December 22, 2025 9.70
$0.59 (6.48%)
December 19, 2025 9.11
$0.41 (4.71%)
December 18, 2025 8.70
$0.15 (1.75%)
December 17, 2025 8.55
-$0.02 (-0.23%)
December 16, 2025 8.57
$0.09 (1.06%)
December 15, 2025 8.48
-$0.15 (-1.74%)
December 12, 2025 8.63
-$0.23 (-2.60%)
December 11, 2025 8.86
$0.17 (1.96%)
December 10, 2025 8.69
$0.41 (4.95%)
December 09, 2025 8.28
$0.00 (0.00%)
December 08, 2025 8.28
-$0.26 (-3.04%)
December 05, 2025 8.54
$0.48 (5.96%)
December 04, 2025 8.06
-$0.19 (-2.30%)
December 03, 2025 8.25
-$0.02 (-0.24%)
December 02, 2025 8.27
-$0.12 (-1.43%)
December 01, 2025 8.39
-$0.34 (-3.89%)

Funds holding this stock

Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports